Clinical Trial

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

Name: Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer — clinical trial record (NCT07261592)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This single-center single-arm, open-label prospective clinical trial aimed to evaluate the efficacy and safety of entinostat combined with chemotherapy as second-line therapy for unresectable locally advanced or metastatic bladder cancer.

Trial Details

NCT Number	NCT07261592
Lead Sponsor	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions	Bladder Cancer, Histone Deacetylase Inhibitor, Entinostat, Chemotherapy
Enrollment	29 participants
Start Date	2025-12-01
Primary Completion	2028-09-30 (estimated)
Study Completion	2029-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-12-03